Nanocarrier-Based Antibacterial Agents and Formulations

Dear Colleagues,

Antibiotic resistance is a major threat to global health. Traditional antibiotics are becoming increasingly ineffective as bacteria develop resistance mechanisms. Nanocarriers have emerged as a promising approach for delivering antibacterial agents. Nanocarriers can be designed to target specific bacteria or tissues, improving the efficacy and safety of antibacterial agents.

This Special Issue will focus on the latest research in the field of nanocarrier-based antibacterial agents. Topics of interest include the following:

• The design and synthesis of novel antibacterial agent-loaded nanocarriers;
• The characterization of the antibacterial activity of nanocarriers;
• The delivery of antibacterial agent-loaded nanocarriers to specific targets;
• The in vitro and in vivo safety and efficacy of antibacterial agent-loaded nanocarriers.

This Special Issue is intended for researchers and clinicians working in the field of antibacterial drug delivery. It will be of interest to scientists and engineers working on the design and development of new antibacterial agent-loaded nanocarriers, as well as clinicians who are evaluating the use of nanocarriers in the treatment of bacterial infections.

We invite original research articles, review articles, and short communications on the topics listed above. Manuscripts should be submitted in English and should follow the guidelines of the journal Pharmaceutics.

Dr. Ángel León-Buitimea
Dr. Carla Martins Lopes
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• antibacterial agent-loaded nanocarriers
• antibiotic resistance
• drug delivery
• nanotechnology
• pharmaceutics